Tech Company Financing Transactions
Genapsys Funding Round
Genapsys closed a $32.5 million venture capital round on 1/3/2018. Investors included private investors.
Transaction Overview
Company Name
Announced On
1/3/2018
Transaction Type
Venture Equity
Amount
$32,533,708
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 2 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Cardinal Way 3rd Floor
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
The GenapSys Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology provides a low cost, easy-to-use, fast, and accurate genome sequencing solution. We've enabled an unparalleled run cost and a simplified workflow with the first ever purely electronic sequencing chip, the key component in our fully integrated platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Myers
Chief Financial Officer
Britton Russell
Chief Operating Officer
Mary Stewart
Vice President
Larry Greenfield
VP - Engineering
Kosar Parizi
VP - Engineering
Hamid Rategh
VP - General Counsel
Dana Moss
VP - Human Resources
Radhika Warrier
VP - Product Management
Surekha Karudapuram
Browse more venture capital transactions:
Prev: 1/3/2018: MD Insider venture capital transaction
Next: 1/3/2018: GraftWorx venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs